Cartalax dosage, injected and by mouth

Seven patterns are in circulation, five by injection and two from the Russian products, and each gets its own row instead of an average. Read the source column alongside the amounts, because none of these numbers comes from a human trial. What Cartalax is and what the cell research found are on the Cartalax page.

The spread is wide because each source starts somewhere different. The education site divides a 20 mg vial into small daily doses. The community newsletter gives 1 or 2 mg a day, with course lengths and long breaks much like the Russian capsule label's. The step-up course climbs much higher and appears, in near-identical wording, on two protocol sites that say it's community-reported. The capsule and the drops follow their own labels, and they're swallowed or held under the tongue rather than injected. Nobody has compared these against each other in people, so a lower pattern isn't a weaker version of a higher one, it's a different convention.

Cartalax comes as a freeze-dried powder, and 20 mg is the vial size most of the vendors we track carry, with a few selling 10, 25 or 30 mg. You mix it with bacteriostatic water, which is sterile water with a preservative so one vial can be drawn from more than once, and inject it under the skin. The everyday injected amounts, from the education site and the community newsletter, are 200 mcg to 2 mg a day.

The table shows the units to draw on a U-100 syringe, the kind that holds 100 units in 1 mL, for 1, 2 and 3 mL of water in a 20 mg vial.

Units are math from the chart amounts, with strength rounded to one decimal. Amounts come from a peptide education site (200 mcg), a community newsletter (1 and 2 mg) and two community protocol sites (5 mg, the top of the step-up course).

For 1 or 2 mg a day, 2 mL of water is the easy one to read, since 1 mg is 10 units and 2 mg is 20. The 200 mcg pattern is the fiddly one, at only a couple of units. More water spreads it out, and with 5 mL in a 20 mg vial, 200 mcg is 5 units. For a 10 mg vial or any other amount, the reconstitution calculator does the same math.

Mixing itself is simple. Let the vial come to room temperature, wipe the stopper with an alcohol swab, and run the water slowly down the inside of the glass rather than straight onto the powder. Then swirl it gently until it's clear, like instant coffee you're dissolving without a spoon, and don't shake it. Use a fresh syringe for every dose, so a 20-day course means 20 syringes even when it all comes from one vial.

For storage, the education site and one of the protocol sites both give 2 to 8°C (36 to 46°F) for the mixed vial, which is an ordinary fridge, and a 28-day use-by.

Two Russian Cartalax products are sold as supplements there, and neither is the research vial. The capsule label, as a retailer lists it, gives one or two capsules once or twice a day with meals, for 10 to 30 days, with the course repeated after 4 to 6 months. The label lists the peptide among the ingredients but doesn't say how much is in each capsule, so there's no milligram figure to compare with a vial.

The under-the-tongue drops, sold as Cartalax Lingual, do give a figure. The label lists 0.1 mg of peptide in each mL and directs 5 to 6 drops, about 0.25 to 0.35 mL, under the tongue 10 to 15 minutes before a meal, 3 to 4 times a day. That works out to about 25 to 35 mcg a dose and 75 to 140 mcg a day, in 30-day courses.

Those amounts belong to their own products. A swallowed or under-the-tongue peptide isn't absorbed the way an injection is, so none of these figures carries over to a vial. Choosing between them is mostly practical. Capsules and drops need no water or syringes, while vials are what US research vendors sell, and they're the only form the injected patterns apply to.

You may also see Sigumir sold next to Cartalax. It's a different product, an extract from animal cartilage and bone rather than the synthetic three-amino-acid peptide, so its directions don't apply to Cartalax either.

Once a day. Every injected pattern in the chart is a single daily dose. The capsule label gives one or two doses a day, and the drops three or four.

Ten to thirty days on, mostly. The education site gives 10 to 20 days. The community newsletter gives 10 days at 1 mg, 20 days at 2 mg, or 30 to 60 days at 2 mg. The capsule label gives 10 to 30 days. The step-up course is the outlier, at 12 weeks.

Months off between courses. The capsule label repeats every 4 to 6 months, and the community newsletter gives 4 to 6 months after the short course, 3 to 4 after the 20-day course and 3 to 6 after the long one. None of these breaks comes from a study that compared them.

Time of day. No study or label sets one for the injection. Pick a time you can repeat on every day of the course, and keep a short log of the date, the amount and where you injected, because there's nothing to feel that tells you a dose went in.

For planning, a 10-day course at 1 mg a day is 10 mg in all. A 20-day course at 2 mg a day is 40 mg, and 30 days at 2 mg is 60 mg. The step-up course is in a different league, since even 12 weeks at the starting 2 mg a day would be 168 mg, before it climbs. Compare vendors on the price per milligram against your course total, not on the price of one vial.

A mixed vial goes on a 28-day clock in the fridge the day the water goes in, however much of it you use.

At 1 mg a day a vial lasts 20 days, and at 2 mg a day it lasts 10, both well inside the clock. A 10-day course at 1 mg uses half a vial, and the other half expires long before the next course in 4 to 6 months, which is a reason to buy a 10 mg vial for the short course where a vendor sells one. At 200 mcg a day, a 20 mg vial holds 100 doses but expires at 28 days with about 14 mg unused.

The longer courses take more than one vial. A 20-day course at 2 mg a day needs two 20 mg vials, a 30-day course needs three, and the newsletter's 60-day course needs six. Mix the second vial when the first runs out, not at the start, so each one gets its full 28 days.

No label or study sets Cartalax alongside another peptide. The community newsletter in the chart describes 1 mg a day of Cartalax inside a mix with BPC-157, TB-500 and GHK-Cu, and that's one writer's routine, not a tested combination. The amounts for each are on the BPC-157, TB-500 and GHK-Cu dosage pages. People also run other Khavinson peptides as separate courses, such as Pinealon or Vesugen, and that's reported use, not tested use.

These come from education and protocol sites, not from a study.

Redness or irritation where you injected. It's the reaction education and protocol sites mention most, usually described as mild. People move to a new spot each day, and some stop the course if it lingers or spreads.

Nothing at all. Nobody has published a sign that shows it working from week to week, so raising the amount to feel something has no source behind it.

No human safety study exists for Cartalax, and the open questions, including pregnancy, breastfeeding and other medicines, are on the Cartalax page.